Literature DB >> 21264657

Smaller brain size likely in young adults (<40 years old) with depressive symptoms compared to healthy controls: a retrospective study.

Michito Adachi1, Akiko Shibata, Takamichi Sato, Etsuko Kawaguchi.   

Abstract

PURPOSE: The aim of this study was to determine whether the brain size of young patients with depressive symptoms is smaller than that of healthy controls using magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We retrospectively evaluated brain size by calculating the ratio of the brain area to that of the skull (the brain-to-skull ratio) on routine MRI scans including the splenium of the corpus callosum obtained from 19 patients <40 years old with depressive symptoms in 2009. The controls were 12 healthy individuals <40 years old who underwent MRI for medical examinations.
RESULTS: The mean brain-to-skull ratio of the control group was 0.850 ± 0.022 (range 0.822-0.889), and that of the patient group was 0.819 ± 0.041 (range 0.756-0.878). An unpaired t-test showed a significant difference in the brain-to-skull ratios between these groups (P = 0.011). In particular, in 7 of the 19 patients with longer duration of illness and more severe symptoms, the brainto-skull ratio was 89%-92% of the mean ratio of the control group.
CONCLUSION: The brain size of young patients with depressive symptoms appears to be smaller than that of healthy controls.

Entities:  

Mesh:

Year:  2011        PMID: 21264657     DOI: 10.1007/s11604-010-0509-y

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  33 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Reduced hippocampal volume correlates with executive dysfunctioning in major depression.

Authors:  Thomas Frodl; Annette Schaub; Sandra Banac; Marketa Charypar; Markus Jäger; Petra Kümmler; Ronald Bottlender; Thomas Zetzsche; Christine Born; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

3.  Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?

Authors:  T Ohnishi; H Matsuda; T Tabira; T Asada; M Uno
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

Review 4.  Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications.

Authors:  Robert M Post
Journal:  J Psychiatr Res       Date:  2007-01-18       Impact factor: 4.791

5.  Neuropsychiatric impairments as predictors of mild cognitive impairment, dementia, and Alzheimer's disease.

Authors:  Janet Stepaniuk; Lesley J Ritchie; Holly Tuokko
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008-05-04       Impact factor: 2.035

Review 6.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Authors:  Meera Vaswani; Farzana Kadar Linda; Subramanyam Ramesh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

7.  Morphology of the inner structure of the hippocampal formation in Alzheimer disease.

Authors:  Michito Adachi; Shinobu Kawakatsu; Takaaki Hosoya; Koichi Otani; Tsuguo Honma; Akiko Shibata; Yukio Sugai
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

8.  Anterior cingulate volumes in never-treated patients with major depressive disorder.

Authors:  Kaan Yucel; Margaret C McKinnon; Ramandeep Chahal; Valerie H Taylor; Kathryn Macdonald; Russell Joffe; Glenda M MacQueen
Journal:  Neuropsychopharmacology       Date:  2008-03-26       Impact factor: 7.853

9.  Volumetric MRI study of the insular cortex in individuals with current and past major depression.

Authors:  Tsutomu Takahashi; Murat Yücel; Valentina Lorenzetti; Ryoichiro Tanino; Sarah Whittle; Michio Suzuki; Mark Walterfang; Christos Pantelis; Nicholas B Allen
Journal:  J Affect Disord       Date:  2009-06-21       Impact factor: 4.839

10.  Alcohol-use disorders.

Authors:  Marc A Schuckit
Journal:  Lancet       Date:  2009-01-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.